Related Experiment Video
Updated: Jun 19, 2026

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
Pharmacological significance of glycosylation in therapeutic proteins
1GlycoFi, Inc., a wholly-owned subsidiary of Merck & Co., Inc. 21 Lafayette St., Suite 200, Lebanon, NH 03766, United States. Huijuan_li@merck.com
Abstract:
Glycoproteins represent the major share of marketed and clinical development phase therapeutic proteins. A thorough understanding of the nature and function of the carbohydrate moiety and its impact on pharmacology properties is essential in discovering and developing safe and efficacious glycoprotein biopharmaceuticals. This review summarizes the processes of N-linked and O-linked glycosylation and both established and emerging platforms for expression of recombinant glycoproteins. Recent or illustrative examples of N-linked and/or O-linked glycosylation impacting drug pharmacology properties (including activity, pharmacokinetics, clearance, and immunogenicity) of marketed and developing therapeutic proteins are presented.
Related Concept Videos
Protein Glycosylation
Glycosylation occurs in...
Proteoglycans
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Matrix Proteoglycans and Glycoproteins
Biosynthesis of Polysaccharides
Pharmacogenomics: Identification of New Drug Targets
